Simcere Pharmaceutical Group (2096.HK) Earnings Analysis
Simcere Pharmaceutical Group (2096.HK) next reports earnings on 2026-08-21. Trailing P/E 21.22.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2096.HK next report earnings?
| Next earnings date | 2026-08-21 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
2096.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-25 | 0.3226 HKD | n/a | n/a | n/a |
| 2025-08-21 | 0.2699 HKD | n/a | n/a | n/a |
| 2024-12-31 | 0.1183 HKD | n/a | n/a | n/a |
| 2024-08-21 | 0.1934 HKD | n/a | n/a | n/a |
2096.HK valuation and analyst view
| Trailing P/E | 21.22 |
|---|---|
| Trailing EPS | 0.52523 HKD |
| Price / book | 3.06 |
| Dividend yield | 1.59% |
| Market cap | 34.21B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Simcere Pharmaceutical Group (2096.HK)'s next earnings date?
Simcere Pharmaceutical Group is next scheduled to report on 2026-08-21.
Did 2096.HK beat earnings last quarter?
Consensus estimate data was not available for 2096.HK's 2026-03-25 report.
What is 2096.HK's current P/E ratio and EPS?
2096.HK trades at a trailing P/E of 21.22 on trailing EPS of 0.5252334057903354 HKD.
What do analysts rate 2096.HK?
2096.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.